BSA-bioconjugates were synthesized for production of functionalized protein-based nanoemulsions using high pressure homogenization. These PEGylated nanoemulsions are designed for intravenous administration and drug delivery.
No takes yet. Share an insight, caveat, or question.
Loureiro et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: